CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, introduced its high-throughput Pixel™ Octo system at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany.
Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical company, has completed the acquisition of Ambien® and Ambien CR® in the United States from Sanofi US.
C2N Diagnostics, LLC (“C2N”), which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.
Merck, a leading science and technology company, and The Michael J. Fox Foundation for Parkinson's Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to enhance its industry-leading line of fluid handling solutions.
To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators.
Thermo Fisher Scientific Inc. the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently.
A June 11 online auction by Tiger Group and Liquidity Services features intellectual property and $12 million in medical equipment and inventory from Medrobotics including 23 of the company's groundbreaking Flex and next-gen Flex360 surgical robotics systems.
Terumo Blood and Cell Technologies a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.
ONFAB, a leading European provider of single-use, flexible containment solutions for the pharmaceutical industry, has officially business operations in the United States in conjunction with parent company Savillex.